The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 26, 2011

Filed:

May. 09, 2008
Applicants:

Scott Seiwert, Pacifica, CA (US);

Steven W. Andrews, Longmont, CO (US);

Leonid Beigelman, San Mateo, CA (US);

Lawrence M. Blatt, San Francisco, CA (US);

Brad Buckman, Oakland, CA (US);

Kevin R. Condroski, Lafayette, CO (US);

Yutong Jiang, Longmont, CO (US);

Robert J. Kaus, Longmont, CO (US);

April L. Kennedy, Denver, CO (US);

Timothy S. Kercher, Boulder, CO (US);

Michael A. Lyon, Superior, CO (US);

Bin Wang, Longmont, CO (US);

Inventors:

Scott Seiwert, Pacifica, CA (US);

Steven W. Andrews, Longmont, CO (US);

Leonid Beigelman, San Mateo, CA (US);

Lawrence M. Blatt, San Francisco, CA (US);

Brad Buckman, Oakland, CA (US);

Kevin R. Condroski, Lafayette, CO (US);

Yutong Jiang, Longmont, CO (US);

Robert J. Kaus, Longmont, CO (US);

April L. Kennedy, Denver, CO (US);

Timothy S. Kercher, Boulder, CO (US);

Michael A. Lyon, Superior, CO (US);

Bin Wang, Longmont, CO (US);

Assignees:

InterMune, Inc., Brisbane, CA (US);

Array Biopharma Inc., Boulder, CO (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/4035 (2006.01); A61K 31/428 (2006.01); A61K 31/4025 (2006.01); A61K 31/401 (2006.01); C07D 207/09 (2006.01); C07D 403/12 (2006.01); C07D 417/12 (2006.01);
U.S. Cl.
CPC ...
Abstract

The embodiments provide compounds of the general Formula I, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments provide compounds of the general Formula II, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.


Find Patent Forward Citations

Loading…